Safety of propofol use in children and adolescents: A disproportionality analysis of the Food and Drug Administration adverse event reporting system (FAERS)

被引：0
|
作者：
Li, Hailong [1 ]
Bo, Zhenyan [1 ]
Zhang, Lingli [1 ]
机构：
[1] Sichuan Univ, West China Univ Hosp 2, Dept Pharm, Chengdu, Sichuan, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：334 / 335
页数：2
相关论文
共 50 条
  • [31] Real-World Safety Profile of Luspatercept: A Pharmacovigilance Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS)
    Batra, Akshee
    Singh, Rohit
    Brunstein, Claudio
    Alejos, David
    Adrianzen-Herrera, Diego
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S369 - S369
  • [32] A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
    Pan, Yunyan
    Wang, Yu
    Zheng, Yifan
    Chen, Jie
    Li, Jia
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
    Joerg Putzke
    Scott Haughie
    Kelly H. Zou
    Gopinath M. Ranganna
    BioDrugs, 2021, 35 : 373 - 374
  • [34] Adverse event profiles after brand or generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS)
    Serebruany, V. L.
    Kim, M-H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 437 - 437
  • [35] Priapism associated with antiepileptic drugs: a disproportionality analysis in the food and drug administration's adverse event reporting system
    Pejcic, A.
    Milosavljevic, M.
    Milosavljevic, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S438 - S438
  • [36] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Zou, Shu-peng
    Yang, Hai-yun
    Ouyang, Meng-ling
    Cheng, Qian
    Shi, Xuan
    Sun, Ming-hui
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [37] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    BMC Pharmacology and Toxicology, 24
  • [38] Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib
    Liu, Zhijing
    Wu, Dongzhi
    Ke, Chengjie
    Nian, Qichun
    Chen, Yan
    Huang, Yaping
    Chen, Maohua
    ONCOLOGY, 2024, 102 (12) : 1084 - 1096
  • [39] Disproportionality analysis of emotional and mood disturbances with statins using the Food and Drug Administration adverse event reporting system
    Patterson, Catherine
    Alberdi, Mikel
    Scheer, Darren
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 346 - 346
  • [40] Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Emily E. Leppien
    Bennett J. Doughty
    Karyssa L. Hurd
    Keira N. Strong
    Brian J. Piper
    Kenneth L. McCall
    Clinical Drug Investigation, 2023, 43 : 393 - 399
12345